Acute pulmonary embolism advances in treatment

Journal of Association of Physicians of India

Volumn 56, Issue MAR, 2008, Pages 185-191

  Gupta, S ^a   Gupta, Brig M M ^b  

^a SDM Hospital   (India)

^b ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE DISEASE; ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HUMAN; INSTRUMENTATION; LUNG EMBOLISM; METHODOLOGY; REVIEW;

ACUTE DISEASE; ANGIOGRAPHY; ANTIFIBRINOLYTIC AGENTS; EMBOLECTOMY; FIBRINOLYTIC AGENTS; HUMANS; PULMONARY EMBOLISM; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; URINARY PLASMINOGEN ACTIVATOR;

EID: 41649083172     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Guidelines on diagnosis and management of acute pulmonary embolism. Task force on Pulmonary Embolism. European Society of Cardiology. European Heart J 2000; 16:1301-6.
2. American College of Emergency Physicians, Clinical Policies Committee. Clinical Policy: Critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003;41:257-70
3. British Thoracic Society: Guidelines for the management of suspected acute pulmonary embolism. Thorax 2003;58:470-84.
4. Kucher N, Rossie E, Rosa MD, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006;113:577-82.
5. Langan CJ, Weingart S. New diagnostic and treatment modalities for pulmonary embolism - one path through the confusion. The Mount Sinai Journal of Medicine 2006;73:528-41.
6. Kline JA, Nelson RD, Jackson RE, Courtney DM. Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism - a multicentric US Study. Ann Emerg Med 2002;39:144-52.
7. Brown MD, Vance SJ, Kline JA. An emergency department guidelines for the diagnosis of pulmonary embolism: an outcome study. Acad Emerg Med 2005;12:20-25.
8. Quiroz R, Kucher N, Zou KH, Kipfmueller F, Costello P, Goldhaber SZ, Schoepf UJ. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism. JAMA 2005;293:2012-17.
9. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Popovich J, Quinn DA,Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK. Multi-detector Computed Tomography for acute pulmonary embolism. N Engl J Med 2006; 354: 2383-85.
10. Kostrubiec M, Pruszczy KP,l Bochowicz A, Pacho R, Szulc M, Kaczynska A, Stycznski G, Kuch Wocial A, Abramczyk P, Bartoszewicz Z, Berent H, Kuczynska K. Biomarkers based risk assessment model in acute pulmonary embolism. European Heart J 2005;26:2166-72.
11. Piazza G and Goldhaber SZ. Acute pulmonary embolism. Circulation 2006;114:E42-47.
12. Lohan DG, Cronin CG, Meehan CP, Kee ST, Dake MD, Davidson IR, O-Sullivan GJ. Massive pulmonary embolism with hemodynamic compromise: therapeutic options. Emerg Radiology 2007;13:161-69.
13. Levine M, Hirsh J, Weitz J, Cruickshank M, Neemeh J, Turpie AG, Gent M. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990;98:1473-79.
14. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism - a collaborative study by the PIOPED investigators. Chest 1990;97:528-33.
15. Dalla - Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G. PAIMS-2: Alteplase combined with heparin versus heparin in treatment of acute pulmonary embolism; Plasminogen Activator Italian Multicenter Study 2. J Am Coll Cardiol 1992;20:520-26.
16. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolysm - randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
17. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus Alteplase compared with heparin alone in patients with submassive pulmonary embolism - For the management strategies and prognosis of Pulmonary Embolism - 3 Trial Investigators. N Engl J Med 2002;347:1143-50.
18. Browse NL, James DC. Streptokinase and Pulmonary Embolism. Lancet 1964;2:1039-43.
19. Tibbutt PA, Davies JA, Anderson JA, Fletcher EWL, Hamill J, Holt JM, Thomas L, Lee GDJ, Miller GAH, Sharp AA, Sutton GC. Comparision of controlled trials of streptokinase and Heparin in the treatment of life threatening pulmonary embolism. British Med J 1974;1(5904):343-47.
20. Ly B, Arnesen H, Eie H, et al. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Medica Scand 1978;203:465-70.
21. Dotter CT, Seamon AJ, Rosch J, et al. "Streptokinase and Heparin in treatment of pulmonary embolism - a randomized comparison." Vasc Surg 1979;13:42-52.
22. Jerjes - Sanchez C, Ramirez-Rivera A, de Lourdes GM, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, Pierzo JA, Rosas E. "Streptokinase and heparin versus heparin alone in massive pulmonary embolism - a randomized controlled trial." J Thromb Thrombolysis 1995;2:227-29.
23. Meneveau N, Schiele F, Vuillemenot A, Velette B, Grolliert G, Bernard Y and Bassand JP. Streptokinase vs. Alteplase in massive pulmonary embolism. European Heart J 1997;18:1141-48.
24. Meneveau N, Ming LP, Seronde MF, Mersun N, Schiele F, Caulfield F, Bernard Y, Bassand JP. In-hospital and long-term outcome after submassive and massive pulmonary embolism submitted to thrombolytic therapy. European Heart J 2003;24:1447-54.
25. UPET - Urokinase Pulmonary Embolism Trial. Circulation 1973;Suppl II: 47-48.
26. USPET - Urokinase Streptokinase Pulmonary Embolism Trial. JAMA 1974;229:1606-13.
27. UKEP Study - Multicentre clinical trial on two local regimens of Urokinase in massive pulmonary embolism. European Heart J 1987;8:2-10.
28. Sala S, Galeotti R, Tilli M, Giombi A, Mannella P. Effectiveness and safety of new protocol of intra-pulmonary administration of Urokinase in Massive Pulmonary Embolism. Emergency Radiology 2001;8:326-31.
29. Serra-Prat M, Jovell AJ, Aymerich M. Efficacy and safety of thrombolytic therapy in Pulmonary Embolism - meta-analysis of randomized controlled trials. Med Clin (Barc) 1999;112:685-89.
30. Thabut G, Thabut D, Myers RP, Benrad-Chabert B, Marrah-Chahla R, Mal H, Fournier M. Thrombolytic Therapy for Pulmonary Embolism - A meta-analysis. J Am Coll Cardiol 2002;40:1660-67.
31. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism - a clinical outcome base meta-analysis. Arch Intern Med 2002;162:2537-41.
32. Wan S, Quilan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for initial treatment of pulmonary embolism - a meta-analysis of the randomized controlled trials. Circulation 2004;110:744-49.
33. Meneveau N, Seronde MF, Blonde MC, Legalery P, Petit KD, Briand F, Caulfield F, Schiele F, Bernard Y, Bassand JP. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 2006;129:1043-50.
34. Yalamanchilli K, Fleischer AG, Lehrman SG, Axelrod HI, Lafaro RJ, Sarabhu MR, Zias EA, Moggia RA. Open pulmonary embolectomy for treatment of major pulmonary embolism. Ann Thoracic Surg 2004;77:819-23.
35. Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS Mihaljevic T, Rizzo RJ, Cohn LH, Aklog L, Byrue JG. Modern surgical treatment of massive pulmonary embolism - results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surgery 2005;129:1018-23.
36. Dauphine C, Omari B. Pulmonary embolectonmy for acute massive pulmonary embolism. Ann Thorac Surg 2005;79:1240-44.
37. Digonnet A, Moya-Plana A, Aubert S, Fletcher E, Bonnet N, Leprince P, Pavie A, Gandjbakhch I. Acute pulmonary embolism: A current surgical approach. Interact Cardio-Vasc Surg 2007;6:27-29.
38. Kucher N. Catheter intervention in Massive Pulmonary Embolism. Cardiology Rounds, www.cardiologyrounds.org March 2006, Harward Medical School, Vol 10, Issue 3, Brigham and Women's Hospital, Boston, Massachusetts, USA.
39. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, KacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, Nguyen PV, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M. CANADIAN TRIAL - Comparison of low intensity Warfarin therapy with conventional intensity warfarin therapy for long term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349:631-39.
40. Schulmann S, Wahlander K, Lundstrom T, Clason SB, Eriksson H. THRIVE TRIAL -Secondary prevention of venous thromboembolism with oral direct thrombin inhibitors - Ximelegatran. N Engl J Med 2003;349:1713-21
41. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ. PREVENT TRIAL-Long term low intensity warfarin therapy for prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-34.
42. White RH, Zhou H, Kim J, Romano PS. A population based study of the effectiveness of inferior vena cava filters use among patients with venous thromboembolism. Arch Intern Med 2000;160:2033-41.